tiprankstipranks

Bay City Capital Llc Insider Profile

4 Followers
Bay City Capital Llc, Ten Percent Owner at Viracta Therapeutics, holds 5.62M shares in Viracta Therapeutics (Ticker: VIRX), holds 97.84K shares in Poniard Pharmaceuticals (Ticker: PARD), holds 1.26K shares in Madrigal Pharmaceuticals (Ticker: MDGL).
tipranks
Bay City Capital Llc

Bay City Capital Llc
Viracta Therapeutics (VIRX)
Ten Percent Owner

Ranked #1,943 out of 99,024 Corporate Insiders

Profitable Transactions

75%
12 out of 16 Profitable Transactions

Average Return

+36.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$23M
69.76%
19.54%
5.54%
2.05%
3.11% Others
A breakdown of Bay City Capital Llc's holdings

Insider Roles

Enliven Therapeutics
(ELVN)
Ten Percent Owner
Viracta Therapeutics
(VIRX)
Ten Percent Owner
Xilio Therapeutics
(XLO)
Ten Percent Owner
Kezar Life Sciences
(KZR)
Ten Percent Owner
+3 other positions
Roles that Bay City Capital Llc holds in companies

Most Profitable Insider Trade

Stock:
Nevro Corp
(NVRO)
Rating:Informative Buy
Date:Nov 05, 2014 - Nov 05, 2015
Return:+179.10%
The most profitable trade made by Bay City Capital Llc

Bay City Capital Llc's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Viracta Therapeutics
Jul 28, 2015
Ten Percent Owner
Uninformative Sell
2.20M
$4.54M
Poniard Pharmaceuticals
Ten Percent Owner
$30.23K
Madrigal Pharmaceuticals
Dec 07, 2021
Ten Percent Owner
Uninformative Sell
$277.50K
Kezar Life Sciences
Jun 28, 2018
Ten Percent Owner
Uninformative Buy
$476.01K
Enliven Therapeutics
Mar 16, 2020
Ten Percent Owner
Uninformative Buy
$16.21M
Xilio Therapeutics
Oct 26, 2021
Ten Percent Owner
Uninformative Buy
$1.29M
Nevro Corp
Jun 17, 2015
Former 10% Beneficial Owner
Informative Sell
23.58M
$414.99K
EPZM
Epizyme
Jan 12, 2016
Informative Buy
5.00M
$4.97M
~DERM
Dermira
Oct 08, 2014
Uninformative Buy
$1.23M
~RSLS
ReShape Lifesciences
Sep 26, 2011
Informative Buy
1.39M
$662.30K
HPTX
Hyperion Therapeutics
Oct 21, 2013
Informative Sell
5.20M
List of latest transactions for each holding click on a transaction to see Bay City Capital Llc's performance on stock

Bay City Capital Llc insider profile FAQ

What is the percentage of profitable transactions made by Bay City Capital Llc?
The percentage of profitable transactions made by Bay City Capital Llc is 75%.
    What is the average return per transaction made by Bay City Capital Llc?
    The average return per transaction made by Bay City Capital Llc is 36.20%.
      What stocks does Bay City Capital Llc hold?
      Bay City Capital Llc holds: VIRX, PARD, MDGL, KZR, ELVN, XLO, NVRO, EPZM, ~DERM, ~RSLS, HPTX stocks.
        What was Bay City Capital Llc’s latest transaction?
        Bay City Capital Llc latest transaction was an Uninformative Sell of $2.20M.
          What was Bay City Capital Llc's most profitable transaction?
          Bay City Capital Llc’s most profitable transaction was an Informative Buy of NVRO stock on November 5, 2014. The return on the trade was 179.10%.
            What is Bay City Capital Llc's role in Viracta Therapeutics?
            Bay City Capital Llc's role in Viracta Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.